EFFECTS AND PRODUCTS. The project consists of the construction of a modern knowledge management portal and scientific potential of the Jagiellonian University – Collegium Medicum (UJ CM) and the inclusion of the portal for the Polish Medical Platform (PPM) (PPM was co-financed as part of the second application call – 2.3.1. AFTER THE PC. Ppm currently consolidates the scientific resources of 7 Polish medical universities and the Institute of Labour Medicine in Łódź. The inclusion of the Kraków Centre in the co-creation of the PPM will be an important contribution strengthening cooperation in the implementation of this project and increasing the results of the PPM on many levels. In total, the visibility of achievements of Polish medicine in the world will be significantly improved, the establishment of scientific contacts and cooperation between research centres and entrepreneurs will be facilitated. With consolidated information on a single platform, it will be possible to create reports and analyses supporting decision-making processes and applying for grants. The aim of the project is to increase the availability of scientific resources of UJ CM by depositing them on design servers in electronic form and bearing metadata, as well as making available within the framework of the Polish Medical Platform, in formats adapted to machine processing. TASKS OF THE PROJECT: Z1: Preparation of application documentation. Z2: Preparation of IT infrastructure and system implementation in UJ CM. Z3: Preparing resources for introduction into the system, introduction and making available of resources. Z4: Launching the system as part of the PPM. Z5: Project promotion and user training. Indirect costs will also be borne within the project. TARGET GROUPS OF THE PROJECT: Scientific and administrative staff. I'm a PhD student. Editors of scientific journals. Individual users (representatives of the socio-economic environment, including: specialists in the field of public health, employees of research laboratories, designers of rehabilitation devices, research equipment, pharmaceutical companies, biotechnology, etc.).